{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:41:28Z","timestamp":1775187688664,"version":"3.50.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,3,15]]},"DOI":"10.2169\/internalmedicine.1699-23","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T22:12:10Z","timestamp":1691532730000},"page":"861-865","source":"Crossref","is-referenced-by-count":2,"title":["Late-onset Myoclonic Seizure in a 78-year-old Woman with Gaucher Disease"],"prefix":"10.2169","volume":"63","author":[{"given":"Nanaka","family":"Yamaguchi-Takegami","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"},{"name":"Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"},{"name":"Department of Health Administration\/Prevention Medicine, Sanraku Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Chikada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"},{"name":"Department of Neurology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine Joyce L","family":"Porto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Takegami","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Sakuishi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"},{"name":"Department of Neurology, Teikyo University Chiba Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ishiura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Health Administration\/Prevention Medicine, Sanraku Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"},{"name":"Department of Physical Therapy, Faculty of Medical Health, Tokyo University of Technology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"},{"name":"Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Japan"},{"name":"Institute of Medical Genomics, International University of Health and Welfare, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides. II. Evidence of an Enzymatic deficiency in Gaucher&apos;s disease. Biochem Biophys Res Commun 18: 221-225, 1965.","DOI":"10.1016\/0006-291X(65)90743-6"},{"key":"2","unstructured":"2. Sidransky E. Gaucher disease: insights from a rare Mendelian disorder. Discov Med 14: 273-281, 2012."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Roshan Lal T, Sidransky E. The spectrum of neurological manifestations associated with gaucher disease. Diseases 5: 10, 2017.","DOI":"10.3390\/diseases5010010"},{"key":"4","unstructured":"4. Alaei MR, Tabrizi A, Jafari N, Mozafari H. Gaucher Disease: new expanded classification emphasizing neurological features. Iran J Child Neurol 13: 7-24, 2019."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tsuji S, Choudary PV, Martin BM, et al. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher&apos;s disease. N Engl J Med 316: 570-575, 1987.","DOI":"10.1056\/NEJM198703053161002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Capablo JL, Franco R, de Cabez\u00f3n AS, Alfonso P, Pocovi M, Giraldo P. Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase\/miglustat combination. Epilepsia 48: 1406-1408, 2007.","DOI":"10.1111\/j.1528-1167.2007.01074.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Amaral O, Lacerda L, Marc\u00e3o A, Pinto E, Tamagnini G, S\u00e1 Miranda MC. Homozygosity for two mild glucocerebrosidase mutations of probable Iberian origin. Clin Genet 56: 100-102, 1999.","DOI":"10.1034\/j.1399-0004.1999.560117.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Guimar\u00e3es J, Amaral O, S\u00e1 Miranda MC. Adult-onset neuronopathic form of Gaucher&apos;s disease: a case report. Parkinsonism Relat Disord 9: 261-264, 2003.","DOI":"10.1016\/S1353-8020(02)00096-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Neudorfer O, Giladi N, Elstein D, et al. Occurrence of Parkinson&apos;s syndrome in type I Gaucher disease. QJM 89: 691-694, 1996.","DOI":"10.1093\/qjmed\/89.9.691"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Iwanami S, Namba K, Tsukada T, et al. Multiple space-occupying lesions of the spleen in a case of Gaucher&apos;s disease. Intern Med 31: 557-560, 1992.","DOI":"10.2169\/internalmedicine.31.557"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mitsui J, Mizuta I, Toyoda A, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 66: 571-576, 2009.","DOI":"10.1001\/archneurol.2009.72"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Park JK, Orvisky E, Tayebi N, et al. Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup. Pediatr Res 53: 387-395, 2003.","DOI":"10.1203\/01.PDR.0000049515.79882.94"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tayebi N, Callahan M, Madike V, et al. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 73: 313-321, 2001.","DOI":"10.1006\/mgme.2001.3201"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Neil JF, Glew RH, Peters SP. Familial psychosis and diverse neurologic abnormalities in adult-onset Gaucher&apos;s disease. Arch Neurol 36: 95-99, 1979.","DOI":"10.1001\/archneur.1979.00500380065007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Larsen SD, Wilson MW, Abe A, et al. Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain. J Lipid Res 53: 282-291, 2012.","DOI":"10.1194\/jlr.M021261"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wilson MW, Shu L, Hinkovska-Galcheva V, et al. Optimization of eliglustat-based glucosylceramide synthase inhibitors as substrate reduction therapy for Gaucher disease type 3. ACS Chem Neurosci 11: 3464-3473, 2020.","DOI":"10.1021\/acschemneuro.0c00558"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim JW, Liou BB, Lai MY, Ponce E, Grabowski GA. Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populations. Hum Mutat 7: 214-218, 1996.","DOI":"10.1002\/(SICI)1098-1004(1996)7:3<214::AID-HUMU5>3.3.CO;2-Y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kowarz L, Goker-Alpan O, Banerjee-Basu S, et al. Gaucher mutation N188S is associated with myoclonic epilepsy. Hum Mutat 26: 271-273, 2005.","DOI":"10.1002\/humu.20217"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rosenbloom B, Balwani M, Bronstein JM, et al. The incidence of parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells Mol Dis 46: 95-102, 2011.","DOI":"10.1016\/j.bcmd.2010.10.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Collins LM, Williams-Gray CH, Morris E, Deegan P, Cox TM, Barker RA. The motor and cognitive features of Parkinson&apos;s disease in patients with concurrent Gaucher disease over 2 years: a case series. J Neurol 265: 1789-1794, 2018.","DOI":"10.1007\/s00415-018-8908-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Machaczka M, Rucinska M, Skotnicki AB, Jurczak W. Parkinson&apos;s syndrome preceding clinical manifestation of Gaucher&apos;s disease. Am J Hematol 61: 216-217, 1999.","DOI":"10.1002\/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.0.CO;2-B"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bembi B, Zambito Marsala S, Sidransky E, et al. Gaucher&apos;s disease with Parkinson&apos;s disease: clinical and pathological aspects. Neurology 61: 99-101, 2003.","DOI":"10.1212\/01.WNL.0000072482.70963.D7"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/6\/63_1699-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:31:28Z","timestamp":1715574688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/6\/63_1699-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1699-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"article-number":"1699-23"}}